Coloplast A/S (CPH:COLO.B)
505.60
+6.10 (1.22%)
Nov 20, 2026, 11:34 AM CET
Coloplast Ratios and Metrics
Market cap in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 113,845 | 94,098 | 122,266 | 196,855 | 167,956 | 164,708 | |
Market Cap Growth | -11.99% | -23.04% | -37.89% | 17.21% | 1.97% | -23.07% |
Enterprise Value | 134,852 | 117,084 | 145,755 | 220,492 | 189,216 | 184,449 |
Last Close Price | 499.50 | 417.90 | 519.71 | 814.78 | 677.77 | 687.34 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 37.07 | 30.61 | 33.63 | 38.97 | 35.12 | 35.00 |
Forward PE | 19.99 | 16.23 | 21.87 | 35.61 | 27.34 | 28.98 |
PS Ratio | 3.93 | 3.25 | 4.39 | 7.28 | 6.86 | 7.30 |
PB Ratio | 7.96 | 6.58 | 7.58 | 10.97 | 9.71 | 19.86 |
P/FCF Ratio | 17.19 | 14.21 | 22.90 | 123.04 | 52.39 | 39.48 |
P/OCF Ratio | 14.21 | 11.75 | 18.40 | 71.17 | 39.74 | 32.30 |
PEG Ratio | 3.51 | 2.01 | 2.25 | 3.71 | 2.69 | 2.93 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
EV/Sales Ratio | 4.66 | 4.05 | 5.23 | 8.16 | 7.72 | 8.17 |
EV/EBITDA Ratio | 15.47 | 13.91 | 16.89 | 26.92 | 25.00 | 24.45 |
EV/EBIT Ratio | 18.10 | 15.72 | 18.88 | 30.17 | 27.63 | 26.66 |
EV/FCF Ratio | 20.36 | 17.69 | 27.30 | 137.81 | 59.02 | 44.21 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Debt / Equity Ratio | 1.51 | 1.51 | 1.40 | 1.26 | 1.13 | 2.26 |
Debt / EBITDA Ratio | 2.47 | 2.47 | 2.54 | 2.67 | 2.50 | 2.40 |
Debt / FCF Ratio | 3.25 | 3.25 | 4.24 | 14.14 | 6.10 | 4.48 |
Net Debt / Equity Ratio | 1.47 | 1.47 | 1.35 | 1.22 | 1.08 | 2.18 |
Net Debt / EBITDA Ratio | 2.50 | 2.50 | 2.51 | 2.67 | 2.47 | 2.40 |
Net Debt / FCF Ratio | 3.17 | 3.17 | 4.06 | 13.65 | 5.82 | 4.33 |
Asset Turnover | 0.61 | 0.61 | 0.58 | 0.56 | 0.57 | 0.85 |
Inventory Turnover | 2.43 | 2.43 | 2.35 | 2.44 | 2.44 | 2.51 |
Quick Ratio | 0.41 | 0.41 | 0.94 | 0.62 | 0.37 | 0.72 |
Current Ratio | 0.74 | 0.74 | 1.61 | 1.02 | 0.61 | 1.20 |
Return on Equity (ROE) | 20.21% | 20.21% | 21.35% | 28.67% | 37.38% | 57.18% |
Return on Assets (ROA) | 6.50% | 6.50% | 7.54% | 10.50% | 11.18% | 17.66% |
Return on Invested Capital (ROIC) | 16.60% | 16.27% | 11.75% | 15.25% | 17.45% | 29.00% |
Return on Capital Employed (ROCE) | 22.70% | 22.70% | 18.40% | 19.30% | 21.50% | 23.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Earnings Yield | 2.70% | 3.27% | 2.97% | 2.57% | 2.85% | 2.86% |
FCF Yield | 5.82% | 7.03% | 4.37% | 0.81% | 1.91% | 2.53% |
Dividend Yield | 4.55% | 5.51% | 4.24% | 2.52% | 2.81% | 2.58% |
Payout Ratio | 36.63% | 36.63% | 31.00% | 93.43% | 88.79% | 85.87% |
Buyback Yield / Dilution | - | - | -0.22% | -4.36% | -1.27% | 0.19% |
Total Shareholder Return | 4.55% | 5.51% | 4.02% | -1.85% | 1.54% | 2.77% |